Nitric Oxide Therapy Systems Market Size, Share, Forecast 2033

Description
Table of Contents

The global nitric oxide therapy systems market is expected to grow at a CAGR of around 5.0% during 2024-2033. This report on global nitric oxide therapy systems market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global nitric oxide therapy systems market by segmenting the market based on product type, end-user, and region. Also, detailed profiles of companies operating in the nitric oxide therapy systems market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

The growing demand for nitric oxide therapy systems for neonatal care is another driver of the nitric oxide therapy system market. Persistent pulmonary hypertension (PPHN) is a life-threatening condition that can occur in newborns and is characterized by high pulmonary artery pressure and low oxygen saturation. Nitric oxide therapy works by selectively dilating the pulmonary vasculature and improving blood flow to the lungs, reducing pulmonary hypertension and improving oxygenation. Moreover, the rising elderly population is one of the key drivers of the nitric oxide therapy system market. As people age, their risk of developing respiratory disorders such as chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and pulmonary hypertension increases.

Market Restraints

Limited reimbursement for nitric oxide therapy systems can be a significant barrier to their adoption and can restrict the growth of the market. Nitric oxide therapy systems are expensive to produce and deliver, and without adequate reimbursement, healthcare providers may be hesitant to use them in their treatment protocols. Reimbursement for medical treatments and devices is typically determined by government healthcare programs and private insurance companies. The availability of alternative treatments can be a significant barrier to the growth of the nitric oxide therapy system market. There may be other treatment options available for respiratory and cardiovascular conditions that are less expensive or easier to administer than nitric oxide therapy systems.

Market Opportunities

The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis, is driving the demand for nitric oxide therapy systems. These diseases affect millions of people worldwide and are a leading cause of morbidity and mortality. Moreover, nitric oxide therapy has also been shown to be effective in treating acute respiratory distress syndrome (ARDS), which is a life-threatening condition that can occur in patients with severe respiratory infections, including COVID-19. The COVID-19 pandemic had led to a surge in demand for nitric oxide therapy systems as healthcare providers seek new treatments for patients with severe respiratory symptoms. Further, government initiatives have played a significant role in driving the growth of the nitric oxide therapy system market. These initiatives have been focused on increasing awareness of the benefits of nitric oxide therapy and promoting the development and adoption of these systems. Here are some ways in which government initiatives have contributed to the growth of the nitric oxide therapy system market.

Industry Development

In Feb 2024, Third Pole Therapeutics concluded the assessment of their portable inhaled nitric oxide delivery system, known as eNOfit. The early-feasibility study (NCT05867914) has confirmed the safety and practicality of the device. Subsequently, it will undergo further examination in larger randomized trials focusing on safety and efficacy.
In Dec 2023, Mallinckrodt plc, announced that the INOmax® EVOLVE™ DS delivery system has been cleared by the U.S. Food and Drug Administration (FDA) for the delivery of INOmax® (nitric oxide) gas, for inhalation.

Nitric Oxide Therapy Systems Market Report Highlights:

The portable segment dominated the global nitric oxide therapy systems market by product type with 65.9% in 2023. The market for these therapy systems is driven by a growing demand for more effective and convenient treatments for a range of conditions, including respiratory diseases such as chronic obstructive pulmonary disease (COPD) and pulmonary hypertension.
Based on end user, hospitals dominated segment held the largest market share of 74.4% in 2023 and is anticipated to dominate the market over the forecast period. Hospitals are one of the largest end-users of nitric oxide therapy systems and is a major driver of the nitric oxide market. Nitric oxide therapy systems are commonly used in hospital settings to manage respiratory and cardiovascular conditions, such as acute respiratory distress syndrome (ARDS) and pulmonary hypertension.
Europe generated the highest revenue in 2023 with a 33.9% revenue share. The European countries like Germany, United Kingdom, France, Spain, etc., prosperity is attributed to an increase in the use of nitric oxide therapy, supporting government policy, and the existence of state-of-the-art medical facilities.

Historical & Forecast Period

Base Year: 2023

Historical Period: 2019-2023

Forecast Period: 2024-2033

Report’s Unit: US$

4. Global Nitric Oxide Therapy Systems Market, Regional Analysis

Global Nitric Oxide Therapy Systems Market Segmentation

Market by Product Type

Portable
Fixed

Market by End User

Hospitals
Homecare Settings
Others

Market by Region

Europe

Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Sweden
Poland
Rest of Europe

North America

United States
Canada

Asia Pacific

China
Japan
India
South Korea
Australia
ASEAN
Rest of Asia Pacific

Latin America

Mexico
Brazil
Argentina
Chile
Rest of Latin America

Middle East & Africa

Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

List of Mentioned Companies

Report Coverage

Report Feature	Details
Base Year	2023
Historical Period	2019-2022
Forecast Period	2024-2033
Units	US$ Million
Segments Covered	Product Type, End User, Region
Region Covered	Europe, North America, Asia Pacific, Latin America, Middle East and Africa
Companies Covered	Bellerophon Therapeutics, BOC Healthcare, Third Pole, Inc., EKU Elektronik GmbH, VERO Biotech, International Biomedical, Inspiration Healthcare Group (SLE Ltd), Mallinckrodt Pharmaceuticals, Praxair Technology, Inc., Vapotherm, Inc.
Purchase Options	Single User License: US$ 2,999 Five User License: US$ 3,499 Corporate License: US$ 4,499

Research Methodology

During the course of the research study, we conducted extensive primary and secondary research. The research commenced with extensive exploration through secondary sources followed by primary research. With these research methods, we were able to estimate the market size, to identify the factors that promote the growth in this market as well as the factors that hamper the growth in the market.

Comprehensive primary and secondary methods helped us to identify the trends in the market and to project the opportunities that the key players may get during the forecast period. Apart from these approaches, various analytical and statistical approaches were also used during data extraction cleaning, and analysis.

Breakdown of Primary Research Participant's Profiles Post-secondary & primary research, we conducted expert interviews to validate all the information we collected during the course of the study. So, a blend of these three-way approaches helped us in data triangulation and to provide an accurate market scenario in our report.

Key Questions Answered in the Report

What will be the global nitric oxide therapy systems market size and the growth rate in the coming year?
What are the main key factors driving the market?
What are the key market trends impacting the growth of the market?
What are the market opportunities and threats in the market?
What industrial trends, drivers, and challenges are manipulating its growth?
Which are trending factors influencing the market shares of the top regions across the globe?
Who are the key market players in the industry?
What is the impact of Covid19 on the current industry?

1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
2.1. Global Market in 2023
2.2. Impact of COVID-19
2.3. Growth Opportunities and Challenges
2.4. Key Industry Trends
3. Global Market Dynamics
3.1. Introduction
3.2. Market DROs
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Industry Trends
3.4. SWOT Analysis
3.5. Market Value Chain Analysis
3.6. Porter’s Five Forces Analysis
3.7. PESTLE Analysis
3.8. Key Price Indicators
3.9. Ansoff Matrix
3.10. Government Laws and Industry Regulations
4. Global Nitric Oxide Therapy Systems Market Analysis
4.1. Market Portraiture
4.2. Market Size (US$ Million, 2019-2023)
4.3. Market Forecast (US$ Million, 2024-2033)
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Nitric Oxide Therapy Systems Market by Product Type (US$ Million, 2019-2033)
5.1. Introduction
5.2. Portable
5.3. Fixed
5.4. Key Segment Investment Opportunity
6. Global Nitric Oxide Therapy Systems Market by End User (US$ Million, 2019-2033)
6.1. Introductions
6.2. Hospitals
6.3. Homecare Settings
6.4. Others
6.5. Key Segment Investment Opportunity
7. Global Nitric Oxide Therapy Systems Market by Region (US$ Million, 2019-2033)
7.1. Introduction
7.2. Europe
7.3. North America
7.4. Asia Pacific
7.5. Latin America
7.6. Middle East & Africa
7.7. Key Segment Investment Opportunity
8. Europe Nitric Oxide Therapy Systems Market (US$ Million, 2019-2033)
8.1. Introduction
8.2. Key Drivers and Takeaways
8.3. Europe Market Breakup by Product Type
8.4. Europe Market Breakup by End User
8.5. Europe Market Breakup by Country
8.5.1. Germany
8.5.2. United Kingdom
8.5.3. France
8.5.4. Italy
8.5.5. Spain
8.5.6. Russia
8.5.7. Netherlands
8.5.8. Sweden
8.5.9. Poland
8.5.10. Rest of Europe
9. North America Nitric Oxide Therapy Systems Market (US$ Million, 2019-2033)
9.1. Introduction
9.2. Key Drivers and Takeaways
9.3. North America Market Breakup by Product Type
9.4. North America Market Breakup by End User
9.5. North America Market Breakup by Country
9.5.1. United States
9.5.2. Canada
10. Asia Pacific Nitric Oxide Therapy Systems Market (US$ Million, 2019-2033)
10.1. Introduction
10.2. Key Drivers and Takeaways
10.3. Asia Pacific Market Breakup by Product Type
10.4. Asia Pacific Market Breakup by End User
10.5. Asia Pacific Market Breakup by Country
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia
10.5.6. ASEAN
10.5.7. Rest of Asia Pacific
11. Latin America Nitric Oxide Therapy Systems Market (US$ Million, 2019-2033)
11.1. Introduction
11.2. Key Drivers and Takeaways
11.3. Latin America Market Breakup by Product Type
11.4. Latin America Market Breakup by End User
11.5. Latin America Market Breakup by Country
11.5.1. Mexico
11.5.2. Brazil
11.5.3. Argentina
11.5.4. Chile
11.5.5. Rest of Latin America
12. Middle East and Africa Nitric Oxide Therapy Systems Market (US$ Million, 2019-2033)
12.1. Introduction
12.2. Key Drivers and Takeaways
12.3. Middle East and Africa Market Breakup by Product Type
12.4. Middle East and Africa Market Breakup by End User
12.5. Middle East and Africa Market Breakup by Country
12.5.1. Saudi Arabia
12.5.2. Turkey
12.5.3. Iran
12.5.4. United Arab Emirates
12.5.5. Rest of Middle East & Africa
13. Competitive Landscape
13.1. Competitive Dashboard
13.2. Key Industry Strategies Analysis
13.3. Recent Developments
13.4. Market Scenario
14. Company Profiles
14.1. Bellerophon Therapeutics
14.2. BOC Healthcare
14.3. Third Pole, Inc.
14.4. EKU Elektronik GmbH
14.5. VERO Biotech
14.6. International Biomedical
14.7. Inspiration Healthcare Group (SLE Ltd)
14.8. Mallinckrodt Pharmaceuticals
14.9. Praxair Technology, Inc.
14.10. Vapotherm, Inc.

Description